Etiome (Venture)
Funding Details
- Awarder
- Inbox
- Date Award
- April 24, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $50,000,000
Company Info
- Founding Year
- 2021
- Founders
- Avak Kahvejian, Ph.D.
- Company Description
- Etiome is redefining how we detect and preempt disease progression to build a healthier future for patients with chronic and progressive diseases. Its Temporal Biodynamics™ platform is the first end-to-end technology to characterize disease with increased resolution over time and accelerate the development of preemptive medicines that promise better health outcomes.
- Market
- Healthcare
- Location
- Cambridge, MA, USA
- Coinvestors
- Flagship Pioneering